PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia
PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of PCSK9 inhibitors in the primary prevention of IHD in people with HeFH.
Ryan, Aidan
bc0e6613-be8c-4c72-a840-bc8cff8f7016
Nevitt, Sarah J.
782a13bc-019e-4887-b72b-20259781f72b
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Cook, Paul
b8e76445-8d7e-40bf-b97f-e42678e90e57
Ryan, Aidan
bc0e6613-be8c-4c72-a840-bc8cff8f7016
Nevitt, Sarah J.
782a13bc-019e-4887-b72b-20259781f72b
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Cook, Paul
b8e76445-8d7e-40bf-b97f-e42678e90e57
Ryan, Aidan, Nevitt, Sarah J., Byrne, Christopher D. and Cook, Paul
(2018)
PCSK9 inhibition for primary prevention of ischaemic heart disease in heterozygous familial hypercholesterolaemia.
Cochrane Database of Systematic Reviews, 2018 (1), [CD012917].
(doi:10.1002/14651858.CD012917).
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of PCSK9 inhibitors in the primary prevention of IHD in people with HeFH.
Text
CD012917
- Version of Record
More information
e-pub ahead of print date: 9 January 2018
Identifiers
Local EPrints ID: 417650
URI: http://eprints.soton.ac.uk/id/eprint/417650
ISSN: 1469-493X
PURE UUID: c1d411cf-dd96-4651-b22e-543c3c8b6110
Catalogue record
Date deposited: 08 Feb 2018 17:30
Last modified: 16 Mar 2024 06:10
Export record
Altmetrics
Contributors
Author:
Aidan Ryan
Author:
Sarah J. Nevitt
Author:
Paul Cook
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics